Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models

Author(s): Shorooq Khader, Anita Thyagarajan, Ravi P. Sahu*.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 19 , Issue 14 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Despite available treatment options, the overall survival rates of pancreatic cancer patients remain dismal. Multiple counter-regulatory pathways have been identified and shown to be involved in interfering with the efficacy of therapeutic agents. In addition, various known genetic alterations in the cellular signaling pathways have been implicated in affecting the growth and progression of pancreatic cancer. Nevertheless, the significance of other unknown pathways is yet to be explored, which provides the rationale for the intervention of new approaches. Several experimental genetic models have been explored to define the impact of key signaling cascades, and their mechanisms in the pathophysiology as well as treatment approaches of pancreatic cancer. The current review highlights the recent updates, and significance of such genetic models in the therapeutic efficacy of anti-tumor agents including the standard chemotherapeutic agents, natural products, cell signaling inhibitors, immunebased therapies and the combination of these approaches in pancreatic cancer.

Keywords: Pancreatic cancer, genetic models, pancreatic cancer therapies, cellular signaling pathways, immune-based approaches, natural compounds.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [1112 - 1125]
Pages: 14
DOI: 10.2174/1389557519666190327163644
Price: $58

Article Metrics

PDF: 13